e-learning
resources
London 2016
Monday, 05.09.2016
Surgical strategy for complex diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of neoadjuvant therapy to complication rate after surgery for primary lung cancer
Dragan R. Subotic (Belgrade, Republic of Serbia), Milan Savic, Dragan R. Subotic, Nikola Atanasijadis, Dejan Moskovljevic, Ivan Soldatovic, Zeljko Garabinovic
Source:
International Congress 2016 – Surgical strategy for complex diseases
Session:
Surgical strategy for complex diseases
Session type:
Thematic Poster
Number:
2509
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Dragan R. Subotic (Belgrade, Republic of Serbia), Milan Savic, Dragan R. Subotic, Nikola Atanasijadis, Dejan Moskovljevic, Ivan Soldatovic, Zeljko Garabinovic. Influence of neoadjuvant therapy to complication rate after surgery for primary lung cancer. Eur Respir J 2016; 48: Suppl. 60, 2509
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Contribution of adjuvant chemotherapy in stage I pulmonary adenocarcinoma after surgical resection
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Reduced perioperative mortality after centralization of lung cancer surgery
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Completion pneumonectomy for lung cancer relapse after surgery- What is a real benefit?
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Surgical treatment outcomes on early-stages of non-small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Segmentectomy for second lung cancer after lobectomy
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
The rate of curative intended therapy against recurrent lung cancer before and after introduction of a CT-based follow-up program
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Futile thoracotomy in lung cancer
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Preoperative pulmonary rehabilitation in female patients undergoing a thoracotomy for lung cancer
Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery
Year: 2014
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Robot-assisted operations in the diagnosis and treatment of intrathoracic tumors
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Sleeve lung resection for non-small cell lung cancer after induction therapy: A safe method
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016
Efficacy of preoperative comprehensive pulmonary rehabilitation in patients with lung cancer
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016
Electrospray-mediated local chemotherapy of lung carcinoma in mice
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Locoregional recurrence after pulmonary segmentectomy of non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Algorithm of preoperative N-staging of non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Smoking at the time of curative-intent lung cancer surgery dramatically influences peri-operative complications
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Characteristics of smoking behaviour in patients post-curative resection of stage 1 lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Single-institution experience of surgical management of metastasises of colorectal cancer in lungs: Lessons learned
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Clinico-pathological prognostic factors for relapse in early stage non-small cell lung cancer after radical surgical resection
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept